WITHDRAWN: Executive Summary - The International Society for Heart and Lung
Transplantation (ISHLT) guidelines for the care of heart transplant recipients - ScienceDirect Skip …

Stem cells offer new therapeutic avenues for the repair and replacement of damaged tissues
and organs owing to their self-renewal and multipotent differentiation capabilities. In this …

There is an urgent need for therapeutic interventions for desensitization and antibody-
mediated rejection (AMR) in sensitized patients with preformed or de novo donor-specific …

Background Sensitized heart transplant candidates spend more time and have higher
mortality on the waiting list. Although the calculated panel-reactive antibody (CPRA) value is …

The treatment of end-stage heart failure has evolved substantially with advances in medical
treatment, cardiac transplantation, and mechanical circulatory support (MCS) devices such …

BACKGROUND The new heart allocation system in the United States prioritizes patients
supported by temporary mechanical circulatory support (TMCS) devices over those with …

Heart transplantation (HT) remains the preferred therapy for patients with advanced heart
failure. However, for sensitized HT candidates who have antibodies to human leukocyte …

Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …

Background Donor-specific HLA antibodies (DSA) are associated with increased rates of
rejection and of graft failure in cardiac transplantation. The goal of this study was to …

Background Allosensitization in heart transplant candidates is associated with longer
transplant wait times and post-transplant complications. We summarize our experience with …